Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
105,863,294
-
Number of holders
-
418
-
Total 13F shares, excl. options
-
78,953,366
-
Shares change
-
-2,953,905
-
Total reported value, excl. options
-
$5,792,808,674
-
Value change
-
-$256,092,991
-
Put/Call ratio
-
209%
-
Number of buys
-
217
-
Number of sells
-
-214
-
Price
-
$73.40
Significant Holders of CORCEPT THERAPEUTICS INC - Common Stock (CORT) as of Q2 2025
520 filings reported holding CORT - CORCEPT THERAPEUTICS INC - Common Stock as of Q2 2025.
CORCEPT THERAPEUTICS INC - Common Stock (CORT) has 418 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 78,953,366 shares
of 105,863,294 outstanding shares and own 75% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (12,530,789 shares), VANGUARD GROUP INC (9,680,592 shares), INGALLS & SNYDER LLC (7,722,922 shares), RENAISSANCE TECHNOLOGIES LLC (6,266,402 shares), Parallel Advisors, LLC (3,871,123 shares), STATE STREET CORP (2,967,587 shares), DIMENSIONAL FUND ADVISORS LP (2,085,517 shares), GEODE CAPITAL MANAGEMENT, LLC (1,915,616 shares), MORGAN STANLEY (1,614,093 shares), and FMR LLC (1,356,948 shares).
This table shows the top 418 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.